Gabapentinoids (gabapentin and pregabalin) are widely prescribed for older people. Case reports have previously documented an association with Atrial Fibrillation, and Spanish researchers have explored this potential relationship further. Older patients without pre-existing cardiovascular disease and treated with a gabapentinoid were compared to patients who initiated treatment with an analgesic opiate or with alprazolam or diazepam. Treatment with an oral anticoagulant plus an antiarrhythmic drug (OAC + AA), or an oral anticoagulant or an antiplatelet agent plus an antiarrhythmic drug (OAC/APA + AA), in the 3 months after treatment initiation were used as surrogate markers for the onset of AF. Both of the gabapentinoids were associated with an apparent substantial increased risk of AF – further research is urgently needed given the widespread and growing use of these drugs. Read more here
Recent Posts
Archives
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018